Walleye Capital
TEVA icon

Walleye Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Walleye Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.5K Buy
+2,309
New +$74.3K ﹤0.01% 3800
2025
Q4 		– Sell
-69,150
Closed -$1.7M – 5130
2025
Q3 		$1.4M Sell
69,150
-72,041
-51% -$1.27M 0.01% 1839
2025
Q2 		$2.37M Sell
141,191
-122,066
-46% -$1.97M 0.01% 1383
2025
Q1 		$4.05M Sell
263,257
-745,626
-74% -$13.3M 0.02% 928
2024
Q4 		$22.2M Sell
1,008,883
-94,177
-9% -$1.71M 0.05% 298
2024
Q3 		$19.9M Buy
1,103,060
+949,026
+616% +$16.6M 0.04% 331
2024
Q2 		$2.5M Buy
154,034
+152,639
+10,942% +$2.35M ﹤0.01% 1891
2024
Q1 		$19.7K Sell
1,395
-225,056
-99% -$2.84M ﹤0.01% 4933
2023
Q4 		$2.36M Buy
226,451
+187,581
+483% +$1.75M 0.01% 1664
2023
Q3 		$396K Buy
+38,870
New +$362K ﹤0.01% 2989
2020
Q1 		– Sell
-13,752
Closed -$135K – 1638
2019
Q4 		$135K Sell
13,752
-136,318
-91% -$1.22M 0.01% 1281
2019
Q3 		$1.03M Buy
+150,070
New +$1.15M 0.06% 437
2019
Q2 		– Sell
-16,218
Closed -$196K – 2030
2019
Q1 		$254K Buy
+16,218
New +$286K 0.04% 672

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Capital's TEVA Position: Q1 2026 in Review

Walleye Capital opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2026: 2,309 shares worth $69.5K. The stake represents ﹤0.01% of the portfolio and ranks #3800 among its holdings. This is a return to the name: Walleye Capital previously reported a position in TEVA as recently as Q3 2025.

Walleye Capital first reported a position in TEVA in Q1 2019 and has held it in 13 quarters since. The position peaked at $22.2M in Q4 2024. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Walleye Capital held 2,309 shares of Teva Pharmaceuticals worth $69.5K as of Q1 2026.
  • Teva Pharmaceuticals was a new Walleye Capital position in Q1 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3800 holding.
  • Walleye Capital first reported a position in Teva Pharmaceuticals in Q1 2019 and has held it in 13 quarters since.
  • Walleye Capital's Teva Pharmaceuticals position peaked at $22.2M in Q4 2024.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.